157 related articles for article (PubMed ID: 15763635)
1. Ketamine reduces cholinergic modulated GABA release from rat striatal slices.
Grasshoff C; Gillessen T; Wagner E; Thiermann H; Szinicz L
Toxicol Lett; 2005 Apr; 156(3):361-7. PubMed ID: 15763635
[TBL] [Abstract][Full Text] [Related]
2. [Ketamine inhibits n-methyl-d-aspartate (NMDA) receptor mediated acetylcholine release from rabbit caudate nucleus slices].
Feuerstein TJ
Anaesthesist; 1994 Nov; 43 Suppl 2():S48-51. PubMed ID: 7840414
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
Hamrouni AM; Gudka N; Broadley KJ
Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
[TBL] [Abstract][Full Text] [Related]
4. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
Marcos B; Gil-Bea FJ; Hirst WD; García-Alloza M; Ramírez MJ
Eur J Neurosci; 2006 Sep; 24(5):1299-306. PubMed ID: 16987217
[TBL] [Abstract][Full Text] [Related]
5. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
Lavoute C; Weiss M; Rostain JC
Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
[TBL] [Abstract][Full Text] [Related]
6. Ketamine induces hyperactivity in rats and hypersensitivity to nicotine in rat striatal slices.
Rodvelt KR; Kracke GR; Schachtman TR; Miller DK
Pharmacol Biochem Behav; 2008 Nov; 91(1):71-6. PubMed ID: 18639577
[TBL] [Abstract][Full Text] [Related]
7. Effect of MK-801 on dopamine release evoked by hypoxia combined with hypoglycemia.
Milusheva E
Acta Physiol Hung; 1992; 79(4):347-54. PubMed ID: 1343187
[TBL] [Abstract][Full Text] [Related]
8. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
9. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
Fantin M; Marti M; Auberson YP; Morari M
J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
[TBL] [Abstract][Full Text] [Related]
10. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
Adams BW; Bradberry CW; Moghaddam B
Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
[TBL] [Abstract][Full Text] [Related]
11. Endogenous GABA release from rat striatal slices: effects of the GABAB receptor antagonist 2-hydroxy-saclofen.
Mayfield RD; Zahniser NR
Synapse; 1993 May; 14(1):16-23. PubMed ID: 8390105
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats.
Antoniou K; Kehr J; Snitt K; Ogren SO
Br J Pharmacol; 1997 Jul; 121(6):1180-6. PubMed ID: 9249255
[TBL] [Abstract][Full Text] [Related]
13. 3-Nitropropionic acid exacerbates [3H]GABA release evoked by glucose deprivation in rat striatal slices.
Boireau A; Meunier M; Doble A
J Pharm Pharmacol; 1996 Jan; 48(1):85-9. PubMed ID: 8722502
[TBL] [Abstract][Full Text] [Related]
14. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.
Pinault D
Biol Psychiatry; 2008 Apr; 63(8):730-5. PubMed ID: 18022604
[TBL] [Abstract][Full Text] [Related]
15. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
Gartside SE; Cole AJ; Williams AP; McQuade R; Judge SJ
Eur J Neurosci; 2007 May; 25(10):3001-8. PubMed ID: 17509083
[TBL] [Abstract][Full Text] [Related]
16. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task.
Monteiro Moreira K; Lima Ferreira T; Vecchio Fornari R; Perez Figueredo LZ; Menezes Oliveira MG
Brain Res Bull; 2005 Nov; 67(6):504-8. PubMed ID: 16216700
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor blockade augmented nicotine-evoked dopamine release from rat prefrontal cortex slices.
Rodvelt KR; Schachtman TR; Kracke GR; Miller DK
Neurosci Lett; 2008 Aug; 440(3):319-22. PubMed ID: 18579301
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis.
Smolders I; Bogaert L; Ebinger G; Michotte Y
J Neurochem; 1997 May; 68(5):1942-8. PubMed ID: 9109520
[TBL] [Abstract][Full Text] [Related]
20. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression.
Wirtshafter D
Brain Res; 2006 Apr; 1085(1):127-31. PubMed ID: 16564505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
